Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A minimalist illustration of a speech bubble and stethoscope representing NLP in healthcare.

Jul 23, 2026

NLP in Healthcare & Life Sciences Market to Surge to USD 30.06

The NLP in Healthcare and Life Sciences market is poised for substantial growth, projected to reach USD 30.06 billion by 2031, driven by advancements in AI technologies.According to a report by MarketsandMarkets, the market for Natural Language Processing (NLP) in healthcare was valued at USD 5.92 billion in 2025 and is expected to grow significantly, with a compound annual growth rate (CAGR) of 29.9%. This surge is primarily fueled by the increasing integration of large language models and gene
A medical device on a table with Kigali's skyline in the background at dusk.

Jul 23, 2026

Irembo and Gates Foundation discuss AI and digital health opportunities for Rwanda’s digital future

Recent discussions between Rwanda’s digital public services platform, Irembo, and the Gates Foundation highlighted the potential of AI and digital health in enhancing service delivery in Rwanda.The meeting, which included key figures from Rwanda’s digital ecosystem such as the Ministry of ICT and Innovation and the Rwanda Information Society Authority, centered on expanding digital infrastructure and integrating artificial intelligence into public services. Irembo showcased its citizen-focused a
Minimalist illustration of an antibody structure

Jul 23, 2026

Creative Biolabs launches end-to-end AI-driven antibody solutions

Creative Biolabs has introduced a comprehensive AI-driven platform designed to revolutionize the antibody discovery process in biopharmaceuticals, significantly reducing timelines for early-stage development.This innovative framework integrates generative deep-learning models with high-throughput experimental workflows, addressing common structural challenges in drug development. Traditional antibody discovery often suffers from high attrition rates due to unfavorable biophysical properties and
A glass vial with a colorful drug compound in a lab setting

Jul 23, 2026

Insilico Medicine and Bora Pharmaceuticals sign strategic partnership worth up to $2.5 billion

Insilico Medicine has formed a strategic partnership with Bora Pharmaceuticals, potentially worth up to $2.5 billion, to enhance AI-driven drug discovery and pharmaceutical development.This collaboration aims to merge Insilico's Pharma.AI platform with Bora's extensive expertise in drug development, manufacturing, and commercialization. By doing so, the companies intend to create a more streamlined process for bringing innovative therapies to market, significantly reducing the time from drug dis
A minimalist illustration of a magnifying glass and data graph in a dark palette.

Jul 23, 2026

Q&A: Exploring how Tecan’s recent Agentic AI offering will benefit laboratories

Tecan's recent integration of Agentic AI into its Introspect platform represents a significant advancement in laboratory automation, enhancing proactive management capabilities for scientists.The introduction of Agentic AI allows laboratories to anticipate and prevent errors rather than merely responding to them. This proactive approach enables scientists to set up an Error Diagnosis AI Agent, which analyzes past data to identify correlations between ongoing experiments and previous mistakes. Fo
A minimalist illustration of a test tube with bubbles, symbolizing chemical reactions in drug discovery.

Jul 23, 2026

An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the Numbers

MindWalk Holdings Corp. has reported a significant 46% increase in revenue, signaling a successful transition toward a recurring revenue model in the AI-driven drug discovery sector.In its latest fiscal year results, MindWalk Holdings Corp. (NASDAQ: HYFT) showcased a remarkable shift in its business approach, reporting a revenue increase to C$15.6 million, up from C$10.6 million the previous year. This growth coincided with a substantial reduction in net loss, which halved to C$13.9 million. The
A modern desk with a notepad and pen in a dimly lit office, symbolizing innovation in life sciences funding.

Jul 23, 2026

CARPL.ai, Wiffy, Farm Watt Innovations, others bag early-stage funding

Recent funding rounds have propelled several startups in the life sciences and tech sectors, showcasing the growing intersection of AI and healthcare solutions.CARPL.ai, a California-based radiology AI platform, has successfully closed a $10 million Series A funding round, primarily led by the International Finance Corporation. This funding aims to enhance product innovation and expand its global partner ecosystem, focusing on markets across North America, Latin America, Europe, and Asia-Pacific
A bottle of generic medication on a pharmacy shelf in low light.

Jul 23, 2026

India pharma market enters US tariff transition with strong domestic growth: Report

India's pharmaceutical sector is poised for growth as it navigates upcoming US tariff changes, according to a recent Equirus Securities report.The report highlights that India's pharmaceutical market is experiencing robust domestic growth momentum as it prepares for a two-year transition period before the United States imposes tariffs on imported generic medications. These tariffs, announced by US President Donald Trump, will maintain a zero percent rate for two years starting August 1, 2026, be
A sleep mask on a bed in a cozy bedroom setting

Jul 23, 2026

Sleep Cycle signs tech licensing agreement with Ant Group

Sleep Cycle has entered into a significant licensing agreement with Ant Group, enhancing its footprint in the rapidly evolving Chinese market for AI-driven digital health solutions.The partnership involves Ant Group integrating Sleep Cycle’s advanced AI-based audio technology into its digital health services, utilizing a one-year pilot license. This move aims to make Sleep Cycle's innovative contactless sleep analysis accessible to a vast user base through Ant Group's Alipay platform, which conn
A minimalist illustration of a cloud with circuit patterns, representing cloud-native technology in life sciences.

Jul 23, 2026

Nordic Capital announces agreement to sell ArisGlobal to Dassault Systèmes, following its transformation into a scaled and AI-enabled life sciences platform

Nordic Capital has announced a definitive agreement to sell ArisGlobal to Dassault Systèmes, marking a significant milestone in the evolution of ArisGlobal as a leading software provider in the life sciences sector. This transaction represents Nordic Capital's full exit from its investment, following a successful partnership that transformed ArisGlobal into a robust, cloud-native platform enhanced by AI capabilities.Founded in 1989, ArisGlobal has developed its flagship LifeSphere® platform, whi
A syringe and medical chart in a dimly lit examination room

Jul 23, 2026

Health services buying AI before national safeguards exist, alliance warns

The Australian Alliance for AI in Healthcare emphasizes the urgent need for ongoing oversight of artificial intelligence applications in the medical field.According to the Alliance, the current regulatory framework for medical devices is insufficient to address the rapid advancements in AI technologies. As these systems evolve, the potential risks and implications for patient safety and care quality increase, necessitating a more dynamic and responsive approach to regulation.This call for contin
A minimalist cloud icon representing data storage in AI.

Jul 23, 2026

Dassault Systèmes confirms 2026 outlook, bets on AI with $1.8 billion ArisGlobal deal

Dassault Systèmes has reaffirmed its 2026 financial outlook while announcing a significant acquisition aimed at enhancing its AI capabilities in the life sciences sector.The French software giant reported second-quarter revenues of €1.56 billion (approximately $1.80 billion), reflecting a 4% increase at constant currencies, largely fueled by growth in subscription and cloud software sales. In a strategic move to bolster its position in the life sciences domain, Dassault Systèmes plans to acquire